Get started
Source

Drug Science Policy and Law

Homepage: us.sagepub.com
ISSN: 2050-3245
Source type: journal
Publisher: SAGE Publishing
Alternate name: Drug science, policy & law
Fully OA: No
DOAJ: No
Article Processing Charge: $3,900
OpenAlex ID: S4210227935
Constructing drug effects: A history of set and setting
2017 · Ido Hartogsohn · Drug Science Policy and Law · 472
PDF
The early use of MDMA (‘Ecstasy’) in psychotherapy (1977–1985)
2018 · Torsten Passie · Drug Science Policy and Law · 116
PDF
Exploring the impact of the opioid epidemic in Black and Hispanic communities in the United States
2020 · Jasmine Drake, Creaque Charles, et al. · Drug Science Policy and Law · 73
Percentages of problem drug use and their implications for policy making: A review of the literature
2020 · Anne Katrin Schlag · Drug Science Policy and Law · 66
PDF
2019: A year of expansion in psychedelic research, industry, and deregulation
2020 · Jacob S Aday, Emily K Bloesch, et al. · Drug Science Policy and Law · 60
Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy
2017 · James W.B. Elsey · Drug Science Policy and Law · 57
PDF
Decriminalization of drug possession in Oregon: Analysis and early lessons
2023 · Kellen Russoniello, Sheila P. Vakharia, et al. · Drug Science Policy and Law · 44
Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary
2015 · Ben Sessa, Friederike Meckel Fischer · Drug Science Policy and Law · 40
Khat ( Catha edulis ): A systematic review of evidence and literature pertaining to its harms to UK users and society
2013 · Sophie Thomas, Tim Williams · Drug Science Policy and Law · 39
Minorities’ diminished psychedelic returns
2023 · Sean M Viña, Amanda L Stephens · Drug Science Policy and Law · 31
PDF
2018: A watershed year for psychedelic science
2019 · Jacob S Aday, Christopher C Davoli, et al. · Drug Science Policy and Law · 30
Can psilocybin be safely administered under medical supervision? A systematic review of adverse event reporting in clinical trials
2022 · Jeremy Roscoe, Olivia Lozy · Drug Science Policy and Law · 29
‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology
2020 · Kenzi Riboulet-Zemouli · Drug Science Policy and Law · 29
PDF
De-mythologizing and re-branding of kava as the new ‘world drug’ of choice
2019 · S Apo Aporosa · Drug Science Policy and Law · 29
PDF
Psychedelics as potential catalysts of scientific creativity and insight
2022 · Sam Gandy, Valérie Bonnelle, et al. · Drug Science Policy and Law · 26
PDF
The risk of being culpable for or involved in a road crash after using cannabis: A systematic review and meta-analyses
2021 · Michael A. White, Nicholas R. Burns · Drug Science Policy and Law · 26
The 15th anniversary of the Portuguese drug policy: Its history, its success and its future
2017 · Tiago S Cabral · Drug Science Policy and Law · 26
PDF
A lexicon for psychedelic research and treatment
2025 · David J. Nutt, David Erritzoe, et al. · Drug Science Policy and Law · 24
The Cathinone Hydra: Increased Cathinone and caffeine adulteration in the English MDMA market after Brexit and COVID-19 lockdowns
2022 · Pascoe MJ, Radley S, et al. · Drug Science Policy and Law · 24
PDF
An effective hangover treatment: Friend or foe?
2017 · Marlou Mackus, Marith van Schrojenstein Lantman, et al. · Drug Science Policy and Law · 24
Characteristics of and 3-month health outcomes for people seeking treatment with prescribed cannabis: Real-world evidence from Project Twenty21
2023 · Michael T Lynskey, Anne K Schlag, et al. · Drug Science Policy and Law · 22
PDF
From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia
2023 · Octavian Victor Brinzei, Cameron N Donley, et al. · Drug Science Policy and Law · 22
Can prescribed medical cannabis use reduce the use of other more harmful drugs?
2020 · Rosalind Gittins, Ben Sessa · Drug Science Policy and Law · 22
PDF
Specific harm reduction strategies employed by 3,4-methylenedioxymethamphetmine/ ecstasy users in the United States and the United Kingdom
2017 · Alan K Davis, Harold Rosenberg · Drug Science Policy and Law · 22
Substance misuse-related poisoning deaths, England and Wales, 1993–2016
2018 · SA Handley, JD Ramsey, et al. · Drug Science Policy and Law · 16
PDF
Works count: 138
Citation count: 1,775
H-index: 22
I10-index: 39
2yr mean citedness: 2.36
Year
Topic
Type